Hematoporphyrin dihydrochloride
CAS: 17696-69-4
Ref. 3D-FH52434
1g | 346,00 € | ||
2g | 506,00 € | ||
5g | 947,00 € | ||
250mg | 136,00 € | ||
500mg | 195,00 € |
Información del producto
- 2,18-Porphinedipropionic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-, dihydrochloride
- 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-, dihydrochloride
- 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-, hydrochloride (1:2)
- 3,3'-[7,12-Bis(1-Hydroxyethyl)-3,8,13,17-Tetramethylporphyrin-2,18-Diyl]Dipropanoic Acid Dihydrochloride
- 3,3'-{7,12-bis[(1R)-1-hydroxyethyl]-3,8,13,17-tetramethylporphyrin-2,18-diyl}dipropanoate
- Haematopophyrin dihydrochloride
- Hematoporphyrin IX dihydrochloride
- Hematoporphyrin hydrochloride
Hematoporphyrin dihydrochloride is an antioxidative agent that has been shown to have therapeutic benefits in the treatment of esterase-deficient porphyria. It is also used in the diagnosis and treatment of other disorders, such as lysis, enhancement, and erythropoietic protoporphyria. Hematoporphyrin dihydrochloride has been shown to induce tumor cell death by reducing ATP levels. This compound is a reactive molecule that can cause damage to the mitochondrial membrane potential and decrease the amount of oxygen consumed by tumor cells. Hematoporphyrin dihydrochloride also increases anti-angiogenic factors (VEGF) by inhibiting the expression of vascular endothelial growth factor receptor 2 (VEGFR2).
Propiedades químicas
Consulta técnica sobre: 3D-FH52434 Hematoporphyrin dihydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.